<code id='FAD45A95F5'></code><style id='FAD45A95F5'></style>
    • <acronym id='FAD45A95F5'></acronym>
      <center id='FAD45A95F5'><center id='FAD45A95F5'><tfoot id='FAD45A95F5'></tfoot></center><abbr id='FAD45A95F5'><dir id='FAD45A95F5'><tfoot id='FAD45A95F5'></tfoot><noframes id='FAD45A95F5'>

    • <optgroup id='FAD45A95F5'><strike id='FAD45A95F5'><sup id='FAD45A95F5'></sup></strike><code id='FAD45A95F5'></code></optgroup>
        1. <b id='FAD45A95F5'><label id='FAD45A95F5'><select id='FAD45A95F5'><dt id='FAD45A95F5'><span id='FAD45A95F5'></span></dt></select></label></b><u id='FAD45A95F5'></u>
          <i id='FAD45A95F5'><strike id='FAD45A95F5'><tt id='FAD45A95F5'><pre id='FAD45A95F5'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:1
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          PhRMA sues HHS over Medicare drug price negotiation
          PhRMA sues HHS over Medicare drug price negotiation

          PhRMAissuingtheBidenadministrationoveritsnewMedicaredrugpricenegotiationprogram.GraemeSloan/SipaUSAW

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          A new deal aims to ramp up use of AI in rehab care decisions

          You’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Signuptog